Clinicopathological and survival profile of patients with salivary gland myoepithelial carcinoma: A systematic review.
Luccas LavarezeJoão Figueira ScariniReydson Alcides de Lima SouzaTalita de Carvalho KimuraRogério de Oliveira GondakFernanda Viviane MarianoAlbina AltemaniFernanda Viviane MarianoPublished in: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2022)
Salivary gland myoepithelial carcinoma showed no sex predilection, with a higher incidence in the parotid gland. Cell type, growth pattern, and treatment type may be related to a lower disease-free survival. Overall, salivary gland myoepithelial carcinoma presented low recurrence and metastasis rates. Registration and protocol: This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 checklist and registered in the International Prospective Register of Systematic Reviews (PROSPERO) database (CRD42022311512).